10x Insights
Loading account…
Companies / Healthcare / Integer Holdings Corp
ITGR

Integer Holdings Corp

HealthcareElectromedical Apparatus
Ticker ITGRPLANO, TXFiscal year ends DecemberBook value per share $50.12Diluted shares 34.3M

Integer Holdings Corporation (ITGR: NYSE) operates as one of the world's largest medical device contract development and manufacturing organizations, serving the Cardio and Vascular, Neuromodulation, and Cardiac Rhythm Management markets. The company maintains its website at www.integer.net. From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-07-03
Sales & profitability
$1.85B
+8.0% year over year
Last 12 mo $1.84B
11.94%
−0.2 percentage points
Last 12 mo 9.70%
$102.81M
−14.3% year over year
Last 12 mo $128.40M
6.68%
−1.3 percentage points
Last 12 mo 7.47%
Cash & financing
$196.15M
−4.4% year over year
Last 12 mo $205.44M
$105.12M
+5.3% year over year
Last 12 mo $111.98M
0.69
Was 0.63× a year earlier
Last 12 mo 0.75
35.6M
−0.2% year over year
Last 12 mo 34.3M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Integer Holdings Corp does

In the company’s own words

Integer Holdings Corporation (ITGR: NYSE) operates as one of the world's largest medical device contract development and manufacturing organizations, serving the Cardio and Vascular, Neuromodulation, and Cardiac Rhythm Management markets. The company maintains its website at www.integer.net.

Integer provides comprehensive engineering and manufacturing solutions to large multinational original equipment manufacturers and their subsidiaries. The company operates through three principal product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Other Markets. The Cardio & Vascular segment encompasses interventional cardiology, structural heart, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology applications. The Cardiac Rhythm Management & Neuromodulation segment includes implantable pulse generators, leads, batteries, feedthroughs, and related components for treating heart rhythm disorders and neurological conditions. The company also maintains a Portable Medical business that is winding down operations.

Integer operates manufacturing facilities across the United States, Mexico, Uruguay, Ireland, Malaysia, Costa Rica, and the Dominican Republic. As of December 31, 2025, the company employed approximately 11,000 associates, with 43 percent based in the United States, 25 percent in Mexico, 15 percent in Ireland, and the remainder distributed across other locations. The company's workforce is supported by a contingent workforce of approximately 400 individuals.

The company's major brands include Greatbatch Medical and Lake Region Medical. Integer's customer base is concentrated among large medical device manufacturers, with three customers—Abbott Laboratories, Boston Scientific, and Medtronic—collectively accounting for 49 percent of total sales in 2025. The company maintains firm backlog orders of approximately 675 million dollars as of December 31, 2025, with the majority expected to ship within one year.

Integer pursues a strategic growth strategy centered on tuck-in acquisitions that expand capabilities and market penetration. Recent acquisitions include Biocoat Incorporated, VSi Parylene, and Precision Coating LLC, all completed during 2025. The company holds 731 patents and maintains various license agreements protecting its intellectual property portfolio.

Company details
Sector
Healthcare
Industry
Electromedical Apparatus
Headquarters
PLANO, TX
Fiscal year end
December
CIK
1114483
SIC
3845

Financial performance, year by year

Fiscal 2012–2025 · USD
$-190.64M$366.89M$924.42M$1.48B$2.04B2012201420152016201720182019202020212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Integer Holdings Corp — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

292
funds hold it
0 of 35
superinvestors hold it
$1.64B
held by funds, at market
52.7%
of shares held by funds
2
bond issues held by funds

Largest fund holders · Integer Holdings Corp’s weight in each

iShares Core S&P Small-Cap ETF
IJR · iShares Trust
0.17%of fund net assets
Invesco Small Cap Value Fund
VSCAX · AIM Sector Funds (Invesco Sector Funds)
1.73%of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.10%of fund net assets
VANGUARD SMALL-CAP INDEX FUND
VB · VANGUARD INDEX FUNDS
0.04%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Integer Holdings Corp’s bonds, as funds hold them

Funds report holding 2 issues of Integer Holdings Corp’s debt, $224.25M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 1.89%, maturing 2028 to 2030.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Integer Holdings Corp and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Integer Holdings Corp's earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Integer Holdings Corp's last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.